Real-time enrollment status for this anaplastic ependymoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 10:57 AM UTC
| NCT Number | NCT03750513 |
| Recruiting Status | Recruiting |
| Condition | Anaplastic Ependymoma |
| Phase | Clinical Trial |
| Target Enrollment | 48 participants |
| Active Locations | 2 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | May 20, 2026 (May 20, 2026) |
As of July 13, 2026: Clinical trial NCT03750513 is currently recruiting participants. This clinical trial study for anaplastic ependymoma is actively seeking new participants at 2 locations across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03750513 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03750513 was last updated May 20, 2026 (May 20, 2026). HelloStudys verifies this status automatically.